Sequential administration of gemtuzumab ozogamicin and conventional chemotherapy as first line therapy in elderly patients with acute myeloid leukemia: a phase II study (AML-15) of the EORTC and GIMEMA leukemia groups.
Sequential administration of gemtuzumab ozogamicin and conventional chemotherapy as first line therapy in elderly patients with acute myeloid leukemia: a phase II study (AML-15) of the EORTC and GIMEMA leukemia groups.
复制标题
吉妥珠单抗奥佐米星和常规化疗序贯给药作为老年急性髓系白血病患者的一线治疗：EORTC 和 GIMEMA 白血病组的 II 期研究 (AML-15)。
作者：
Amadori,Sergio;Suciu,Stefan;Willemze,Roel;Mandelli,Franco;Selleslag,Dominique;Stauder,Reinhard;Ho,Anthony;Denzlinger,Claudio;Leone,Giuseppe;Fabris,Piero;Muus,Petra;Vignetti,Marco;Hagemeijer,Anne;Beeldens,Filip;Anak,Ozlem;DeW
